Sales at Japan's Terumo up 12%
This article was originally published in Clinica
Japanese company Terumo recorded sales of ¥16 billion ($922 million), up 12%, in the year ended March 1997. After-tax profits were Yen9 billion, up 316%. Sales of the company's blood transfusion devices rose 10% to Yen15 billion, with sales of injection devices increasing 6% to Yen17 billion, reports Reuters. Terumo said the increase was due to strengthened production and sales facilities abroad, the expansion of sales centres in Japan, new product launches and a weaker yen. The company hopes to record sales of Yen123 billion in 1998, an increase of 6%.